Cell MedX closes $75k private placement; director and spouse subscribe $30k

Stimcell Energetics Inc.

Issued 2,500,000 units at $0.03/unit for gross proceeds of $75,000.
Each unit includes one common share and one warrant (exp. March 12, 2026).
Warrant exercise price: $0.04/share until Sep 12, 2024, then $0.05 thereafter.
Director Amir Vahabzadeh and his spouse acquired 1,000,000 units ($30,000).
Offering exempt under Reg S and Rule 506(b); securities unregistered.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Stimcell Energetics Inc. entered into Private Placement Subscription Agreement with Amir Vahabzadeh valued at 30,000 USD (effective 2024-03-12).

Action: entry
Agreement: equity purchase
Counterparty: Amir Vahabzadeh
Value: 30,000 USD
Effective: 2024-03-12

Exact text from the filing

On March 12, 2024, Amir Vahabzadeh, a director of Cell MedX Corp. (the "Company"), together with his spouse, subscribed for 1,000,000 units (each a "Unit") of the Company at a price of US$0.03 per Unit for total $30,000 in a private placement offering (the "Offering").

View on SEC.gov

547 material agreements filed in the last 30 days. Browse all material agreements →

Stimcell Energetics Inc. filing history →

Source: SEC EDGAR

accession 0001393905-24-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.